Key Cannabis Exec Changes You Need To Know About: Leafly’s New CCO, Glass House’s New Appointment & More
Leafly Names New CCO
Leafly Holdings, Inc. (NASDAQ: LFLY) announced that Carlos Pinto joined the company as a chief commercial officer.
Westlake Set To Join S&P MidCap 400, Replacing MillerKnoll; MillerKnoll To Replace Covetrus In S&P SmallCap 600
Westlake Corp. (NYSE:WLK) will replace MillerKnoll Inc. (NASD:MLKN) in the S&P MidCap 400, and MillerKnoll will replace Covetrus Inc. (NASD:CVET) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 18.
Looking Into Covetrus’s Return On Capital Employed
Covetrus (NASDAQ:CVET) brought in sales totaling $1.22 billion during Q2 according to data provided by Benzinga Pro. However, earnings decreased 100.0%, resulting in a loss of $4.00 million.
Covetrus: Q2 Earnings Insights
Covetrus (NASDAQ:CVET) reported its Q2 earnings results on Thursday, August 4, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
Stifel Downgrades Covetrus to Hold, Announces $22 Price Target
Stifel analyst Jonathan Block downgrades Covetrus (NASDAQ:CVET) from Buy to Hold and announces $22 price target.
Benzinga’s Top Ratings Upgrades, Downgrades For May 25, 2022
Upgrades
Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.
CD&R, TPG Take Covetrus Private In $4B Deal
Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services…